Characteristics of the participating studies: North Africa (54 studies).

aHER2 testing was performed but not included in the review because it was not possible to estimate the standard error as the sample size was NK.bOnly HR+ (ER+ and/or PR+) estimates are provided.cOnly HR+ (defined as subtypes Luminal A + Luminal B) estimates are provided.dOnly the results from IHC (versus ICH) were included in the review.AJCC, American Joint Committee on Cancer; BC, breast cancer; IBC, inflammatory breast cancer; IDC, invasive ductal carcinoma; ICH, immunocytochemistry; IgG, Immunoglobulin G; MR, medical records; n/a, not applicable; NK, not given in the paper; NOS, not otherwise specified.Characteristics of the participating studies: North Africa (54 studies).